We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Tronox
TROX
$877M
| $3.39M | 0.01% |
+668,036
| New | +$3.64M |
|
827
Cummins
CMI
$79B
| $3.38M | 0.01% |
10,318
-3,415
| -25% | -$1.06M |
|
828
ManpowerGroup
MAN
$2.89B
| $3.37M | 0.01% |
83,495
-691
| -0.8% | -$30.2K |
|
829
Dropbox
DBX
$7.8B
| $3.37M | 0.01% |
117,852
+92,280
| +361% | +$2.61M |
|
|
SNCY
830
DELISTED
Sun Country Airlines
SNCY
| $3.36M | 0.01% |
285,643
+67,463
| +31% | +$741K |
|
831
Cousins Properties
CUZ
$4.85B
| $3.33M | 0.01% |
110,926
+32,162
| +41% | +$908K |
|
832
NCR Atleos
NATL
$3.4B
| $3.3M | 0.01% |
115,565
+397
| +0.3% | +$10.7K |
|
833
LeMaitre Vascular
LMAT
$1.82B
| $3.29M | 0.01% |
39,659
+155
| +0.4% | +$13K |
|
|
HI
834
DELISTED
Hillenbrand
HI
| $3.29M | 0.01% |
+164,013
| New | +$3.41M |
|
835
Cadence Design Systems
CDNS
$95.7B
| $3.28M | 0.01% |
10,648
-26,625
| -71% | -$7.74M |
|
836
APi Group
APG
$17.8B
| $3.27M | 0.01% |
96,056
+34,056
| +55% | +$975K |
|
837
SGHC Ltd
SGHC
$7.03B
| $3.23M | 0.01% |
+294,653
| New | +$2.5M |
|
838
Xeris Biopharma Holdings
XERS
$1.57B
| $3.23M | 0.01% |
691,381
+3,598
| +0.5% | +$16.5K |
|
839
Amkor Technology
AMKR
$12.9B
| $3.21M | 0.01% |
153,072
+142,315
| +1,323% | +$2.63M |
|
840
Expro Ltd
XPRO
$2.03B
| $3.18M | 0.01% |
+370,230
| New | +$3.14M |
|
|
ARES.PRB
841
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.36B
| – | – |
0
| – | – |
|
842
AGCO
AGCO
$7.77B
| $3.18M | 0.01% |
30,814
-2,973
| -9% | -$283K |
|
843
Black Hills Corp
BKH
$5.6B
| $3.14M | 0.01% |
55,929
+1,543
| +3% | +$90.4K |
|
844
Wabash National
WNC
$539M
| $3.05M | 0.01% |
287,135
-244,484
| -46% | -$2.35M |
|
845
Zillow
ZG
$8.17B
| $3.04M | 0.01% |
44,356
-3
| -0% | -$199 |
|
846
Arteris
AIP
$1.16B
| $3.03M | 0.01% |
318,454
-8,665
| -3% | -$63.9K |
|
847
Aurora
AUR
$11.4B
| $3.03M | 0.01% |
+578,853
| New | +$3.63M |
|
848
Inogen
INGN
$146M
| $2.98M | 0.01% |
423,320
+18,425
| +5% | +$124K |
|
849
Pricesmart
PSMT
$5.34B
| $2.98M | 0.01% |
28,323
-5,318
| -16% | -$537K |
|
850
Magna International
MGA
$17.6B
| $2.97M | 0.01% |
77,033
+19,760
| +35% | +$698K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.